Physician profile
Morgan E Hott
NPI 1902006117
$15,722.18
in general payments reported to CMS, 2019-2025
34 companies · $966 in 2025
The $966 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,401 · 2020: $2,145 · 2021: $2,984 · 2022: $2,882 · 2023: $2,135 · 2024: $2,209 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,031 · Education: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,030.83 |
| Education | $279.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,492.61 | 2019-2025 | |
| Janssen Biotech, INC. | $2,513.95 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $1,243.05 | 2019-2025 | |
| Lilly USA, LLC | $873.97 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $793.16 | 2019-2025 | |
| Ucb, INC. | $765.45 | 2019-2025 | Bimzelx |
| Leo Pharma INC. | $732.96 | 2020-2024 | Adbry |
| Regeneron Healthcare Solutions, INC. | $652.84 | 2020-2025 | Dupixent, Libtayo |
| Janssen Scientific Affairs, LLC | $593.63 | 2019-2022 | |
| Amgen INC. | $564.74 | 2019-2025 | Otezla |
| Organogenesis INC. | $524.08 | 2021-2025 | Puraply, Via Matrix, Puraply Wound Matrix |
| Mallinckrodt Hospital Products INC. | $515.16 | 2020-2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $484.03 | 2019-2025 | Odomzo, Blu-U |
| E.R. Squibb & Sons, L.L.C. | $377.81 | 2022-2024 | Sotyktu |
| Genentech USA, INC. | $340.10 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $258.94 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.32 | 2022-2025 | Spevigo, Cyltezo |
| Convatec INC. | $111.75 | 2023-2025 | |
| Pfizer INC. | $99.74 | 2019-2023 | |
| Journey Medical Corporation | $92.20 | 2020 | |
| Incyte Corporation | $81.07 | 2022-2023 | Opzelura |
| Sanofi-Aventis U.S. LLC | $79.99 | 2022 | |
| Biocon Biologics INC | $71.31 | 2024 | Hulio |
| Mylan Institutional INC. | $63.79 | 2023 | Hulio |
| Celgene Corporation | $54.83 | 2019 | |
| Sandoz INC. | $33.25 | 2023-2024 | Hyrimoz |
| Qiagen, LLC | $30.70 | 2024 | |
| Prugen, INC. Pharmaceuticals | $24.42 | 2019 | |
| Almirall LLC | $23.55 | 2022 | |
| Dermavant Sciences, INC. | $19.86 | 2023 | Vtama |
| Fresenius Kabi USA, LLC | $19.11 | 2023 | |
| Galderma Laboratories, L.P. | $18.33 | 2021 | |
| Ets Wound Care LLC | $16.53 | 2025 | Mirragen Advanced Wound Matrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Hott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.